Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Major depressive disorder (MDD) is associated with significant impairments in health-related quality of life (HRQoL) and everyday functioning. This cohort study investigated the long-term development of HRQoL in patients with MDD and its association with patient characteristics, including depressive symptom severity and cognitive symptoms. METHODS: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study was a longitudinal cohort study conducted in 1,159 outpatients aged 18-65 years with MDD in France, Germany, Spain, Sweden, and the UK. The patients were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. HRQoL was assessed using the Medical Outcomes Study Short-Form 12-item Health Survey (SF-12) up to month 12 and the EuroQol Five Dimensions questionnaire up to month 24 (UK only). Depressive symptom severity was assessed up to month 24 by the patient-reported Patient Health Questionnaire and cognitive symptoms by the Perceived Deficit Questionnaire. Multivariate analyses were performed to identify patient characteristics associated with HRQoL. RESULTS: Mental HRQoL was severely impaired at baseline versus normative data (mean [SD] SF-12 mental component summary [MCS], 26.5 [9.2]); mean (SD) physical component summary (PCS) total score was 45.2 (12.1). SF-12 MCS improved over 12 months of follow-up (38.7 [11.6] at month 12), while SF-12 PCS remained stable (45.3 [11.1]). At each assessment time point, there was a clear pattern of lower SF-12 MCS and PCS total score in patients experiencing greater cognitive problems. The mean EuroQol Five Dimensions questionnaire utility index score generally decreased (i.e., worsened) with increasing severity of cognitive and depressive symptoms at all time points up to 24 months. Multivariate analyses identified both depression severity and cognitive symptoms as strongly and significantly associated with poor HRQoL. CONCLUSION: These findings highlight the importance of recognizing and managing residual symptoms in patients with MDD, including the cognitive symptoms, to restore long-term psychosocial functioning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?
Karimi, M., & Brazier, J. (2016) · PharmacoEconomics · doi:10.1007/s40273-016-0389-9 · Cited by 1,646
Quality-of-Life Impairment in Depressive and Anxiety Disorders
Rapaport, M. H., Clary, C., Fayyad, R., & Endicott, J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1171 · Cited by 914 · cited 6×
“This has been suggested to be particularly relevant in patients with mental health disorders such as MDD. 57 Analysis of the association between cognitive symptoms and HRQoL assessed using the EQ-5D specifically was limited by the fact that this questionnaire was only used in the UK, thereby reducing the statistical p…”
InfluentialMalhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Residual symptoms after partial remission: an important outcome in depression
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995) · Psychological Medicine · doi:10.1017/s0033291700033146 · Cited by 791 · cited 4×
“28 48 Impairment of HRQoL was also found to be significantly associated with patient-reported depression severity for up to 2 years after initiating or undergoing first switch of antidepressant monotherapy.”
InfluentialMcIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., Alsuwaidan, M., & Baskaran, A. (2013) · Depression and Anxiety · doi:10.1002/da.22063 · Cited by 765
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00138-4 · Cited by 590
The role of cognitive impairment in general functioning in major depression
Baune, B. T., Miller, R., McAfoose, J., Johnson, M., Quirk, F., & Mitchell, D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.12.001 · Cited by 378 · cited 1×
“24 While a growing body of literature continues to uncover the clinical importance of cognitive symptoms in MDD in terms of understanding disease severity and progression, and a number of recent updates of treat-ment guidelines for MDD specifically point to cognitive symptoms as an important…”
Quality of life assessments in major depressive disorder: a review of the literature
Papakostas, G. I., Petersen, T., Mahal, Y., Mischoulon, D., Nierenberg, A. A., & Fava, M. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2003.07.004 · Cited by 331
Quality of life: The ultimate outcome measure of interventions in major depressive disorder
IsHak, W. W., Greenberg, J. M., Balayan, K., Kapitanski, N., Jeffrey, J., Fathy, H., Fakhry, H., & Rapaport, M. H. (2011) · Harvard Review of Psychiatry · doi:10.3109/10673229.2011.614099 · Cited by 313 · cited 6×
“This has been suggested to be particularly relevant in patients with mental health disorders such as MDD. 57 Analysis of the association between cognitive symptoms and HRQoL assessed using the EQ-5D specifically was limited by the fact that this questionnaire was only used in the UK, thereby reducing the statistical p…”
InfluentialLam, R. W., McIntosh, D., Wang, J., Enns, M. W., Kolivakis, T., Michalak, E. E., Sareen, J., Song, W.-Y., Kennedy, S. H., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659416 · Cited by 288
Cotrena, C., Branco, L. D., Shansis, F. M., & Fonseca, R. P. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.007 · Cited by 227
The role of cognitive dysfunction in the symptoms and remission from depression
Gonda, X., Pompili, M., Serafini, G., Carvalho, A. F., Rihmer, Z., & Dome, P. (2015) · Annals of General Psychiatry · doi:10.1186/s12991-015-0068-9 · Cited by 173 · cited 1×
“…and a number of recent updates of treat-ment guidelines for MDD specifically point to cognitive symptoms as an important therapeutic target, 19,22,24–28 little is known about the association between cognitive symptoms and HRQoL during the different stages of MDD progression and treatment.”
IsHak, W. W., Mirocha, J., James, D., Tobia, G., Vilhauer, J., Fakhry, H., Pi, S., Hanson, E., Nashawati, R., Peselow, E. D., et al. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12301 · Cited by 140
ten Doesschate, M. C., Koeter, M. W. J., Bockting, C. L. H., & Schene, A. H. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.026 · Cited by 91
Lin, C.-H., Yen, Y.-C., Chen, M.-C., & Chen, C.-C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.039 · Cited by 57 · cited 1×
“Similarly, the significant association of HRQoL with patient demographic characteristics (country, age, sex, and educational level) over the long term highlights the importance of considering these factors when planning long-term multinational clinical investigations, as the relevance of these factors has so far only…”
Cited by
Cognitive impairment in depression: recent advances and novel treatments
Perini, G., Cotta Ramusino, M., Sinforiani, E., Bernini, S., Petrachi, R., & Costa, A. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s199746 · Cited by 384
Matcham, F., Leightley, D., Siddi, S., Lamers, F., White, K. M., Annas, P., de Girolamo, G., Difrancesco, S., Haro, J. M., Horsfall, M., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03753-1 · Cited by 110
“MDD is associated with a wide range of negative outcomes including: loss of occupational function (3); reduced quality-of-life (4); and premature mortality (5).”
Self-citationSumiyoshi, T., Watanabe, K., Noto, S., Sakamoto, S., Moriguchi, Y., Tan, K. H. X., Hammer-Helmich, L., & Fernandez, J. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.064 · Cited by 70
Self-citationGlutamatergic Modulators for Major Depression from Theory to Clinical Use
McIntyre, R. S., & Jain, R. (2024) · CNS Drugs · doi:10.1007/s40263-024-01114-y · Cited by 69
Jain, S., Gupta, S., Li, V. W., Suthoff, E., & Arnaud, A. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04165-x · Cited by 53
Metadata
- Authors
- Saragoussi, D., Christensen, M. C., Hammer-Helmich, L., Rive, B., Touya, M., & Haro, J. M.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2018-05
- Volume
- Volume 14
- Pages
- 1339-1350
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- OpenAlex
- W2803306181
- Cited by
- 110
- References
- 17
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.